Literature DB >> 32946981

Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature.

Briana Fitch1, Ritu Roy2, Huimin Geng3, Encarnacion Montecino-Rodriguez4, Henrik Bengtsson5, Coline Gaillard3, Kamir Hiam6, David Casero4, Adam B Olshen7, Kenneth Dorshkind8, Scott C Kogan9.   

Abstract

The finding that transformed mouse B-1 and B-2 progenitors give rise to B-cell acute lymphoblastic leukemias (B-ALLs) with varied aggressiveness suggests that B-cell lineage might also be a factor in the initiation and progression of pediatric B-ALLs in humans. If this is the case, we hypothesized that human pediatric B-ALLs would share gene expression patterns with mouse B-1 or B-2 progenitors. We tested this premise by deriving a distinct 30-gene B-1 and B-2 progenitor signature that was applied to a microarray data set of human pediatric ALLs. Cluster analysis revealed that CRLF2, E2A-PBX1, ERG, and ETV6-RUNX1 leukemias were B-1-like, whereas BCR-ABL1, hyperdiploid, and MLL leukemias were B-2-like. Examination of the 30-gene signature in two independent data sets of pediatric ALLs supported this result. Our data suggest that common genetic subtypes of human ALL have their origin in the B-1 or B-2 lineage.
Copyright © 2020 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32946981      PMCID: PMC7606616          DOI: 10.1016/j.exphem.2020.09.184

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  15 in total

Review 1.  Origins of chromosome translocations in childhood leukaemia.

Authors:  Mel F Greaves; Joe Wiemels
Journal:  Nat Rev Cancer       Date:  2003-09       Impact factor: 60.716

2.  Murine B-1 B cell progenitors initiate B-acute lymphoblastic leukemia with features of high-risk disease.

Authors:  Encarnacion Montecino-Rodriguez; Katy Li; Michael Fice; Kenneth Dorshkind
Journal:  J Immunol       Date:  2014-04-21       Impact factor: 5.422

Review 3.  Genetics and prognosis of ALL in children vs adults.

Authors:  Kathryn G Roberts
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

4.  Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways.

Authors:  Sheryl M Gough; Liat Goldberg; Marbin Pineda; Robert L Walker; Yuelin J Zhu; Sven Bilke; Yang Jo Chung; Joseph Dufraine; Subhadip Kundu; Elad Jacoby; Terry J Fry; Susanna Fischer; Renate Panzer-Grümayer; Paul S Meltzer; Peter D Aplan
Journal:  Blood Adv       Date:  2017-09-08

Review 5.  Origin of murine B cell lineages.

Authors:  A B Kantor; L A Herzenberg
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

6.  Transcriptomes of the B and T lineages compared by multiplatform microarray profiling.

Authors:  Michio W Painter; Scott Davis; Richard R Hardy; Diane Mathis; Christophe Benoist
Journal:  J Immunol       Date:  2011-02-09       Impact factor: 5.422

7.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

8.  Distinct Genetic Networks Orchestrate the Emergence of Specific Waves of Fetal and Adult B-1 and B-2 Development.

Authors:  Encarnacion Montecino-Rodriguez; Michael Fice; David Casero; Beata Berent-Maoz; Chad L Barber; Kenneth Dorshkind
Journal:  Immunity       Date:  2016-08-23       Impact factor: 31.745

9.  Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia.

Authors:  Maria E Figueroa; Shann-Ching Chen; Anna K Andersson; Letha A Phillips; Yushan Li; Jason Sotzen; Mondira Kundu; James R Downing; Ari Melnick; Charles G Mullighan
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

10.  Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-.

Authors:  Daniel O Griffin; Nichol E Holodick; Thomas L Rothstein
Journal:  J Exp Med       Date:  2011-01-10       Impact factor: 14.307

View more
  6 in total

1.  Variant to function mapping at single-cell resolution through network propagation.

Authors:  Fulong Yu; Liam D Cato; Chen Weng; L Alexander Liggett; Soyoung Jeon; Keren Xu; Charleston W K Chiang; Joseph L Wiemels; Jonathan S Weissman; Adam J de Smith; Vijay G Sankaran
Journal:  Nat Biotechnol       Date:  2022-06-06       Impact factor: 54.908

Review 2.  Increasing Complexity of Molecular Landscapes in Human Hematopoietic Stem and Progenitor Cells during Development and Aging.

Authors:  Suzanne M Watt; Peng Hua; Irene Roberts
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

Review 3.  The Origin of B-cells: Human Fetal B Cell Development and Implications for the Pathogenesis of Childhood Acute Lymphoblastic Leukemia.

Authors:  Thomas R Jackson; Rebecca E Ling; Anindita Roy
Journal:  Front Immunol       Date:  2021-02-17       Impact factor: 7.561

4.  Ikaros deficiency is associated with aggressive BCR-ABL1 B-cell precursor acute lymphoblastic leukemia independent of the lineage and developmental origin.

Authors:  Célestine Simand; Céline Keime; Aurélie Cayé; Chloé Arfeuille; Marie Passet; Rathana Kim; Hélène Cavé; Emmanuelle Clappier; Philippe Kastner; Susan Chan; Beate Heizmann
Journal:  Haematologica       Date:  2022-01-01       Impact factor: 9.941

5.  Variant to function mapping at single-cell resolution through network propagation.

Authors:  Fulong Yu; Liam D Cato; Chen Weng; L Alexander Liggett; Soyoung Jeon; Keren Xu; Charleston W K Chiang; Joseph L Wiemels; Jonathan S Weissman; Adam J de Smith; Vijay G Sankaran
Journal:  bioRxiv       Date:  2022-01-24

Review 6.  Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia.

Authors:  Wenjuan Liao; M Eric Kohler; Terry Fry; Patricia Ernst
Journal:  Exp Hematol       Date:  2021-07-21       Impact factor: 3.084

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.